ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106. A total of 60 filers reported holding ONCOGENEX PHARMACEUTICALS IN in Q4 2014. The put-call ratio across all filers is 3.99 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $1,351,000 | +61.6% | 628,400 | +72.2% | 0.72% | +57.0% |
| Q4 2014 | $836,000 | -90.3% | 365,000 | -64.7% | 0.46% | -92.4% |
| Q4 2013 | $8,616,000 | -0.4% | 1,033,100 | +10.7% | 6.02% | +40.6% |
| Q3 2013 | $8,650,000 | -5.4% | 933,100 | 0.0% | 4.28% | +18.9% |
| Q2 2013 | $9,144,000 | – | 933,100 | – | 3.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Steamboat Capital Partners, LLC | 817,521 | $414,000 | 0.37% |
| Abingworth LLP | 396,104 | $195,000 | 0.19% |
| BOOTHBAY FUND MANAGEMENT, LLC | 60,638 | $31,000 | 0.01% |
| EAGLE GLOBAL ADVISORS LLC | 128,520 | $65,000 | 0.00% |
| PANAGORA ASSET MANAGEMENT INC | 949,438 | $481,000 | 0.00% |
| Renaissance Technologies | 908,100 | $460,000 | 0.00% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 46,100 | $23,000 | 0.00% |
| DEUTSCHE BANK AG\ | 5 | $0 | 0.00% |
| CITIGROUP INC | 10,376 | $5,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 20,037 | $10,000 | 0.00% |